American Society Of Clinical Oncology

This study looks at whether starting with a lower dose of CDK4/6 inhibitor pills (palbociclib or ribociclib) and slowly increasing the dose helps older adults (65+) with metastatic breast cancer tolerate side effects better and stay on treatment longer. About 500 participants wil…

This study looks at whether giving targeted drugs based on a tumor's specific gene changes can help people with advanced cancer who have run out of standard treatments. It includes adults and teens with solid tumors, multiple myeloma, or non-Hodgkin lymphoma. The goal is to learn…